General Information


DRACP ID  DRACP04082

Peptide Name  

Sequence  RWWWAA

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C45H54N12O7

Absent amino acids  CDEFGHIKLMNPQSTVY

Common amino acids  W

Mass  96437

Pl  10.55

Basic residues  1

Acidic residues  0

Hydrophobic residues  5

Net charge  1

Boman Index  -431

Hydrophobicity  -60

Aliphatic Index  33.33

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  16500

Absorbance 280nm  3300

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33042031

Title  Hybrid Antimicrobial Peptide Targeting Staphylococcus aureu s and Displaying Anti-infective Activity in a Murine Model

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16905

DRACP is developed by Dr.Zheng's team.